PR Newswire (press release) MADRID, June 13, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the results from the CONCERTO trial, the first randomized, controll...
Healio Nearly half of patients with Crohn's disease treated with methotrexate after poor response to thiopurines experienced sustained clinical benefit with relatively few and mild adverse events in a recent study. Researchers assessed the tolerability and ...
